MARKET RELEASE
27 June 2017
The securities of Neuren Pharmaceuticals Limited (the "Company") will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the earlier of the commencement of normal trading on Thursday, 29 June 2017 or when the announcement is released to the market.
Security Code: | NEU |
Violetta Codreanu
ADVISER, LISTINGS COMPLIANCE (SYDNEY)
27 June 2017
Violetta Codreanu
ASX Compliance Pty Limited 20 Bridge Street
Sydney NSW 2000 By Email
Dear Violetta,
TRADING HALT REQUESTThe Directors of Neuren Pharmaceuticals Limited (ASX Code: NEU) hereby request a halt in trading of the Company's securities, effective until market opening on Thursday 29 June 2017, or an earlier announcement by the Company.
The trading halt is requested pending an announcement regarding a capital raising transaction.
The Company is not aware of any reason why the trading halt should not be granted.
Yours sincerely
Jon Pilcher
CFO & Company Secretary
Neuren Pharmaceuticals Limited ARBN 111 496 130
Unit 4, 435 Williamstown Road, Port Melbourne, VIC 3207